Skip to main content
SpringerLink
Log in

Plasma concentration of total and transformed α2-macroglobulin in systemic sclerosis

  • Short Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. LeRoy EC (1992) Clinical comments and a pathophysiological discussion of scleroderma. J Dermatol 19:509–523

    PubMed  CAS  Google Scholar 

  2. Mauch K, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T (1993) Control of fibrosis in systemic scleroderma. J Invest Dermatol 100:92S-96S

    Article  PubMed  CAS  Google Scholar 

  3. Sottrup-Jensen L (1989) α-Macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264:11539–11542

    PubMed  CAS  Google Scholar 

  4. Borth W (1992) α2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6:3345–3353

    PubMed  CAS  Google Scholar 

  5. LaMarre J, Wollenberg K, Gonias SL, Hayes MA (1991) Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab Invest 65:3–14

    PubMed  CAS  Google Scholar 

  6. Kratzsch J, Selisko T, Birkenmeier G (1994) Identification of transformed α2-macroglobulin as a growth hormone binding protein in human blood. J Clin Endocrinol Metab 80:585–590

    Article  Google Scholar 

  7. Sottrup-Jensen L, Birkendal-Hansen H (1989) Human fibroblast collagenase-α2-macroglobulin interactions. J Biol Chem 264:393–401

    PubMed  CAS  Google Scholar 

  8. Enghild JJ, Salvesen G, Brew K, Nagase H (1989) Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (matrix metalloproteinase 3) with human α2-macroglobulin and chicken ovostatin. J Biol Chem 264:8779–8785

    PubMed  CAS  Google Scholar 

  9. Birkenmeier G, Strigbrand T (1993) Production of conformation-specific monoclonal antibodies against α2-macroglobulin and their use for quantitation of total and transformed α2-macroglobulin in human blood. J Immunol Methods 162:59–67

    Article  PubMed  CAS  Google Scholar 

  10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23:581–590

    Google Scholar 

  11. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T (1991) Steady-state, mRNA levels of collagen I, III fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol 97:219–222

    Article  PubMed  CAS  Google Scholar 

  12. Brady AH (1973) Collagenase in scleroderma. J Clin Invest 56:1175–1180

    Article  Google Scholar 

  13. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y (1994) Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103:359–363

    Article  PubMed  CAS  Google Scholar 

  14. Moestrup SK, Gliemann J, Pallesen G (1992) Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375–382

    Article  PubMed  CAS  Google Scholar 

  15. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK (1988) Surface localization and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggests a physiological role as lipoprotein receptor. EMBO J 7:4119–4127

    PubMed  CAS  Google Scholar 

  16. Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorini M, Argraves WS (1990) Sequence identity between the α2-macroglobulin receptor and the low density lipoprotein receptor-related protein suggests that this molecule is a multi-functional receptor. J Biol Chem 265:17401–17404

    PubMed  CAS  Google Scholar 

  17. Soker S, Svahn CM, Neufeld G (1993) Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin. J Biol Chem 268:7685–7691

    PubMed  CAS  Google Scholar 

  18. Bonner JC, Badgett A, Osorinio-Vargas AR, Hoffman M, Brody AR (1990) PDGF-stimulated fibroblast proliferation is enhanced synergistically by receptor-recognized α2-macroglobulin. J Cell Physiol 145:2–7

    Article  Google Scholar 

  19. Needleman BW, Wigley FM, Stair RW (1992) Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon levels in sera from patients with scleroderma. Arthritis Rheum 35:67–72.

    PubMed  CAS  Google Scholar 

  20. Piquet PF, Collart MA, Grau GE, Sappino AP, Vassalli P (1990) Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245–247

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Biochemistry, Faculty of Medicine, University of Leipzig, Liebigstrasse 16, D-04103, Leipzig, Germany

    Gerd Birkenmeier

  2. Department of Dermatology, Faculty of Medicine, University of Leipzig, Liebigstrasse 21, D-04103, Leipzig, Germany

    Roman Frank

Authors
  1. Gerd Birkenmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roman Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Professor Dr. Gerhard Kopperschläger on the occasion of his 60th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birkenmeier, G., Frank, R. Plasma concentration of total and transformed α2-macroglobulin in systemic sclerosis. Arch Dermatol Res 288, 405–407 (1996). https://doi.org/10.1007/BF02507111

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02507111

Key words

Search

Navigation